NCT05099107View on ClinicalTrials.gov

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

March 17, 2025

Study Completion Date

March 17, 2025

Conditions
Congenital MyopathyNeuromuscular DiseasesMusculoskeletal DiseasesNemaline MyopathyCentronuclear MyopathyMyosin Storage Myopathy
Interventions
DRUG

Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet

taken 3 times daily for 6 months

DRUG

Salbutamol Only Product in Oral Dose Form

taken 3 times daily for 6 months

Trial Locations (1)

41650

Sahlgrenska university hospital, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT05099107 - Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment | Biotech Hunter | Biotech Hunter